Alk-Abello AS (AKBLF)
22.05
0.00 (0.00%)
USD |
OTCM |
Nov 21, 16:00
Alk-Abello Debt to Equity Ratio: 0.0372 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2024 | 0.0372 |
June 30, 2024 | 0.0394 |
March 31, 2024 | 0.0424 |
December 31, 2023 | 0.1043 |
September 30, 2023 | 0.0951 |
June 30, 2023 | 0.1097 |
March 31, 2023 | 0.0889 |
December 31, 2022 | 0.1076 |
September 30, 2022 | 0.0952 |
June 30, 2022 | 0.1001 |
March 31, 2022 | 0.105 |
December 31, 2021 | 0.1339 |
September 30, 2021 | 0.1635 |
June 30, 2021 | 0.1684 |
March 31, 2021 | 0.2107 |
December 31, 2020 | 0.2233 |
September 30, 2020 | 0.2214 |
June 30, 2020 | 0.2202 |
March 31, 2020 | 0.2199 |
December 31, 2019 | 0.2283 |
September 30, 2019 | 0.228 |
June 30, 2019 | 0.2307 |
March 31, 2019 | 0.2233 |
December 31, 2018 | 0.2334 |
September 30, 2018 | 0.2271 |
Date | Value |
---|---|
June 30, 2018 | 0.2269 |
March 31, 2018 | 0.2294 |
December 31, 2017 | 0.2304 |
September 30, 2017 | 0.2765 |
June 30, 2017 | 0.2748 |
March 31, 2017 | 0.2731 |
December 31, 2016 | 0.2696 |
September 30, 2016 | 0.2223 |
June 30, 2016 | 0.2234 |
March 31, 2016 | 0.2317 |
December 31, 2015 | 0.2392 |
September 30, 2015 | 0.2549 |
June 30, 2015 | 0.2636 |
March 31, 2015 | 0.1322 |
December 31, 2014 | 0.1376 |
September 30, 2014 | 0.1382 |
June 30, 2014 | 0.1419 |
March 31, 2014 | 0.1422 |
December 31, 2013 | 0.1454 |
September 30, 2013 | 0.1478 |
June 30, 2013 | 0.1485 |
March 31, 2013 | 0.1467 |
December 31, 2012 | 0.1471 |
September 30, 2012 | 0.1437 |
June 30, 2012 | 0.1462 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0372
Minimum
Sep 2024
0.2283
Maximum
Dec 2019
0.1357
Average
0.1086
Median
Debt to Equity Ratio Benchmarks
Genmab AS | 0.00 |
Ascendis Pharma AS | -8.104 |
Galecto Inc | -- |
Evaxion Biotech AS | 0.00 |
IO Biotech Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 1.071B |
Total Liabilities (Quarterly) | 309.00M |
Shareholders Equity (Quarterly) | 761.79M |
Current Ratio | 2.950 |
Net Debt Paydown Yield | 0.13% |